Before that, Eli Lilly launched TuneLab, a platform for an AI drug-discovery model, which it made available to smaller biotechs that wouldn't otherwise be able to build one. Access to the platform is ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback